Related Experiment Video
Updated: Mar 28, 2026
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Ad-PUMA sensitizes ovarian cancer cells to chemotherapeutic agents
1Department of Obstetrics and Gynecology, North China University of Science and Technology Affiliated Hospital, TangShan, HeBei Province, China. yanchen0806@yahoo.com.
Objective:
Ovarian cancer accounted for the first cause of death in female reproductive system tumor even with the operation and chemotherapy. We sought to evaluate the therapeutic potential of p53 up-regulated modulator of apoptosis (PUMA) in ovarian cancer.
Materials And Methods:
An adenovirus expressing PUMA (Ad-PUMA), alone or in combination with chemotherapeutic agents, was used to treat two different ovarian cancer cell lines. The mechanism of PUMA-mediated growth suppression and apoptosis was investigated by analysis of caspase-9 activation and the change of mitochondrial membrane potential (Δψm).
Results:
The exogenous PUMA was expressed 6 h after Ad-PUMA infection, which increased the chemosensitivity of the cancer cells and decreased the IC50 of chemotherapeutic agents compared with uninfected cells. The apoptotic percentage of OVCAR-3 and SKOV3 increased greatly compared with Taxol or Cisplatin alone. There was shear zone in caspase-9 and Δψm decrease after Ad-PUMA infection which suggested apoptosis started in mitochondrial mediated pathway.
Conclusions:
PUMA plays a role in suppressing tumor growth and sensitizing ovarian cancer cells to anticancer drugs and may be a promising tool for cancer biotherapy.
Insights
Puma protein enhances ovarian cancer cell sensitivity to chemotherapy, offering a potential new biotherapy. This study investigated Puma
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ovarian cancer remains a leading cause of death among female reproductive system tumors, despite conventional treatments.
- There is a critical need for novel therapeutic strategies to improve patient outcomes.
Purpose of the Study:
- To evaluate the therapeutic potential of p53 up-regulated modulator of apoptosis (PUMA) in ovarian cancer.
- To investigate PUMA's role in suppressing tumor growth and sensitizing cancer cells to chemotherapy.
Main Methods:
- Adenovirus expressing PUMA (Ad-PUMA) was used to treat ovarian cancer cell lines.
- Mechanisms of PUMA-mediated apoptosis were analyzed via caspase-9 activation and mitochondrial membrane potential (Δψm) changes.
Main Results:
- Exogenous PUMA expression increased cancer cell chemosensitivity and reduced drug IC50 values.
- Ad-PUMA treatment significantly enhanced apoptosis in ovarian cancer cells compared to chemotherapy alone.
- PUMA-induced apoptosis involved the mitochondrial pathway, indicated by caspase-9 activation and Δψm decrease.
Conclusions:
- PUMA plays a significant role in suppressing ovarian tumor growth.
- PUMA sensitizes ovarian cancer cells to anticancer drugs, highlighting its potential in combination therapies.
- PUMA represents a promising candidate for future ovarian cancer biotherapy strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:23Abnormal Proliferation
02:56Treatment Resistant Cancers